Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion type Assertion NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_head.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion wasGeneratedBy ECO_0000203 NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion wasDerivedFrom befree-2016 NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion SIO_000772 1726707 NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion evidence source_evidence_literature NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.
- NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.